Added to YB: 2019-05-01
Pitch date: 2019-05-01
ACHN:US [bullish]
Achillion Pharmaceuticals, Inc.
+129.15%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Achillion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for immune system disorders.
Market Cap
$947.0M
Pitch Price
$2.95
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-12.59
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ACHILLION PHARMACEUTICALS INC ACHN:US
A summary for this pitch has not been created yet.
Read full article (0 min)